China Meheco Group's (SHSE:600056) Profits Appear To Have Quality Issues

Simply Wall StNov 4 17:02 ET

china meheco group (600056.SH): Subsidiary obtains approval notice for pharmaceutical supplementary application.

GeLongHui October 28th 丨 china meheco group (600056.SH) announced that its wholly-owned subsidiary, Hainan Tongyong Sanyo Pharmaceutical Co., Ltd. (referred to as "Sanyo Pharmaceutical"), has received the Approval Notice for Supplementary Application of Injection-grade Roxatidine Acetate Hydrochloride (referred to as "the pharmaceutical") issued by the National Medical Products Administration. The pharmaceutical is a histamine H2 receptor antagonist, which is rapidly converted into the metabolite Roxatidine through ester hydrolysis in the body, effectively inhibiting the basal gastric acid secretion and stimulated gastric acid secretion in animals. The pharmaceutical is indicated for upper gastrointestinal bleeding (caused by peptic ulcers,

Gelonghui FinanceOct 28 07:00 ET

China Meheco Group (600056.SH): Apzolam tablets pharmaceutical pass generic drug consistency evaluation.

Gelonghui October 28th | China Meheco Group (600056.SH) announced that its wholly-owned subsidiary, Tianfang Pharmaceutical Co., Ltd. (referred to as Tianfang Pharmaceutical), received the Approval Notification for the supplementary application for the drug Apzolam Tablet issued by the National Medical Products Administration, which passed the evaluation of generic drug quality and efficacy consistency.

Gelonghui FinanceOct 28 06:59 ET

Full report for the third quarter of 2024

SZSIOct 25 12:00 ET · Announcements

Zhaojin International: China Meheco Group's industry is expected to "outperform the market" Focus on the health insurance opportunities of innovative varieties.

The new round of domestic health insurance negotiations is about to be implemented, although there is certain pressure on health insurance funds, the bank believes that the policy trend of health insurance funds supporting innovative drugs will not change.

Zhitong FinanceOct 20 22:56 ET

The Three-year Decline in Earnings Might Be Taking Its Toll on China Meheco Group (SHSE:600056) Shareholders as Stock Falls 4.1% Over the Past Week

Simply Wall StOct 9 18:15 ET